Page last updated: 2024-11-07

prednisone and Rubinstein-Taybi Syndrome

prednisone has been researched along with Rubinstein-Taybi Syndrome in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Rubinstein-Taybi Syndrome: A chromosomal disorder characterized by MENTAL RETARDATION, broad thumbs, webbing of fingers and toes, beaked nose, short upper lip, pouting lower lip, agenesis of corpus callosum, large foramen magnum, keloid formation, pulmonary stenosis, vertebral anomalies, chest wall anomalies, sleep apnea, and megacolon. The disease has an autosomal dominant pattern of inheritance and is associated with deletions of the short arm of chromosome 16 (16p13.3).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mar, N1
Digiuseppe, JA1
Dailey, ME1

Other Studies

1 other study available for prednisone and Rubinstein-Taybi Syndrome

ArticleYear
Rubinstein-Taybi syndrome - a window into follicular lymphoma biology.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; CREB-Binding Protein; Cyclophosphamide; DNA M

2016